Pharmaceutical Industry

Page 98 of 100

NIGERIA-HEALTH-DISEASE-EPIDEMIC-EBOLA-LIBERIA
International

Technical hurdles, not funding, could hinder race for Ebola vaccines

By
October 27, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
Finance

Allergan firms up its profit as it continues to rebuff Valeant’s advances

By
October 27, 2014
Technology
Finance

Merck’s cost cutting pays off as results beat expectations

By
October 27, 2014
BRITAIN-PHARMACEUTICAL-GSK
International

GlaxoSmithKline moving forward with Ebola vaccine

By
October 22, 2014
Daniel Loeb urges Amgen to split into two companies
Finance

Daniel Loeb urges Amgen to split into two companies

By
October 21, 2014
Management
Leadership

The top 10 best-performing CEOs

By
October 17, 2014
77993380
International

End of the road for inversions? Abbvie drops $55 billion Shire bid

By
October 16, 2014
Abbvie looks like dropping Shire bid after crackdown on tax inversions
International

Abbvie looks like dropping Shire bid after crackdown on tax inversions

By
October 15, 2014
Valeant Offers to Buy Allergan With Pershing's Support
Finance

Valeant seen raising offer for Allergan to clinch deal

By
October 8, 2014
Berlin Hospital Prepares For Possible Ebola Cases
International

Dallas Ebola patient gets experimental drug

By
October 7, 2014
Ebola outbreak’s impact on 5 key industries
International

Ebola outbreak’s impact on 5 key industries

By
October 3, 2014
511882721
International

Salix scraps inversion-based deal to buy Cosmo

By
October 3, 2014
International
Finance

As Ebola spreads, drug companies race to develop treatments

By
October 2, 2014
Berlin Hospital Prepares For Possible Ebola Cases
Finance

Stocks roiled by news of first American Ebola case

By
October 1, 2014
Johnson & Johnson Products Ahead Of Earnings
Finance

J&J buys Alios BioPharma to gain access to infant medicine

By
September 30, 2014

Most Popular